0001104659-15-026765.txt : 20150409 0001104659-15-026765.hdr.sgml : 20150409 20150409164436 ACCESSION NUMBER: 0001104659-15-026765 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150407 FILED AS OF DATE: 20150409 DATE AS OF CHANGE: 20150409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ALBANY GATE, DARKES LANE CITY: POTTERS BAR, HERTS STATE: X0 ZIP: EN6 1AG BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: ALBANY GATE, DARKES LANE CITY: POTTERS BAR, HERTS STATE: X0 ZIP: EN6 1AG FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abbott Investments Luxembourg S.A R.L. CENTRAL INDEX KEY: 0001635614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 15761817 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 BUSINESS PHONE: 224-668-3591 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abbott Established Products Holdings Gibraltar Ltd CENTRAL INDEX KEY: 0001635611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 15761818 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 BUSINESS PHONE: 224-668-3591 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 15761819 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 4 1 a4.xml 4 X0306 4 2015-04-07 0 0001623613 Mylan N.V. MYL 0000001800 ABBOTT LABORATORIES 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6092 0 0 1 0 0001635611 Abbott Established Products Holdings Gibraltar Ltd 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6092 0 0 1 0 0001635614 Abbott Investments Luxembourg S.A R.L. 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6092 0 0 1 0 Ordinary Shares, nominal value Euro 0.01 per share 2015-04-07 4 X 0 5250000 56.8912 D 69750000 I By Subsidiaries Call Option (Obligation to Sell) 56.8912 2015-04-07 4 X 0 1 0 D 2015-03-31 2015-04-30 Ordinary Shares 5250000 0 I By Subsidiaries (1) The Ordinary Shares of Mylan N.V. ("Mylan") described in this report are held directly by Abbott Established Products Holdings (Gibraltar) Limited and Abbott Investments Luxembourg S.a r.l (collectively, the "Subsidiaries"). Each of the Subsidiaries is an indirect, wholly-owned subsidiary of Abbott Laboratories ("Abbott"). In Abbott's capacity as the ultimate corporate parent of the Subsidiaries, Abbott may be deemed to indirectly beneficially own such Ordinary Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission thereunder. (2) On March 31, 2015, the Subsidiaries and Laboratoires Fournier S.A.S., an indirect, wholly-owned subsidiary of Abbott, entered into an Underwriting Agreement (the "Underwriting Agreement") with Morgan Stanley & Co. LLC and Goldman Sachs & Co., as representatives of the several underwriters named therein, and Mylan relating to an underwritten public resale offering an aggregate of 35,000,000 Ordinary Shares. The offering transaction closed on April 6, 2015. Pursuant to the Underwriting Agreement, Abbott Investments Luxembourg S.a r.l, for no additional consideration, granted the underwriters a 30-day option to purchase up to an additional 5,250,000 Ordinary Shares for a purchase price of $56.89125 per Ordinary Share. On April 7, 2015, the representatives of the underwriters exercised the foregoing option in full. Thomas C. Freyman 2015-04-09